Profil
Christophe Bancel is the founder of iBionext SAS, founded in 2012, serving as Venture Partner since 2012.
Mr. Bancel is the founder of Tissium SA, founded in 2013, serving as Chief Executive Officer & Director since 2013.
Former job includes Director at BrainEver SAS.
Aktive Positionen von Christophe Bancel
| Unternehmen | Position | Beginn |
|---|---|---|
Tissium SA
Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Gründer | 01.01.2013 |
iBionext SAS
iBionext SAS Investment ManagersFinance iBionext is an active manager invests in young companies located in France. The firm targets companies operating in the health technology (biotech/medtech/e-health). They provide equity financing for seed, later and growth capital requirements. | Gründer | 01.10.2012 |
Ehemalige bekannte Positionen von Christophe Bancel
| Unternehmen | Position | Ende |
|---|---|---|
Brainever SAS
Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Tissium SA
Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Health Technology |
iBionext SAS
iBionext SAS Investment ManagersFinance iBionext is an active manager invests in young companies located in France. The firm targets companies operating in the health technology (biotech/medtech/e-health). They provide equity financing for seed, later and growth capital requirements. | Finance |
Brainever SAS
Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients | Health Technology |
















